Global expansion of Mycobacterium tuberculosis lineage 4 shaped by colonial migration and local adaptation.
| Title: | Global expansion of Mycobacterium tuberculosis lineage 4 shaped by colonial migration and local adaptation. |
|---|---|
| Authors: | Brynildsrud OB; Division of Infectious Diseases and Environmental Health, Norwegian Institute of Public Health, Lovisenberggata 8, 0456 Oslo, Norway.; Pepperell CS; Division of Infectious Disease, Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53726, USA.; Department of Medical Microbiology and Immunology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53726, USA.; Suffys P; Laboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Institute, Avenida Brasil 4365, C.P. 926, Manguinhos 21040-360, Rio de Janeiro, Brazil.; Grandjean L; Department of Paediatric Infectious Diseases, Imperial College London, W2 1NY, London, UK.; Monteserin J; Instituto Nacional de Enfermedades Infecciosas, ANLIS Carlos Malbran, Buenos Aires, Argentina.; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Buenos Aires, Argentina.; Debech N; Division of Infectious Diseases and Environmental Health, Norwegian Institute of Public Health, Lovisenberggata 8, 0456 Oslo, Norway.; Bohlin J; Division of Infectious Diseases and Environmental Health, Norwegian Institute of Public Health, Lovisenberggata 8, 0456 Oslo, Norway.; Alfsnes K; Division of Infectious Diseases and Environmental Health, Norwegian Institute of Public Health, Lovisenberggata 8, 0456 Oslo, Norway.; Pettersson JO; Division of Infectious Diseases and Environmental Health, Norwegian Institute of Public Health, Lovisenberggata 8, 0456 Oslo, Norway.; Department of Medical Biochemistry and Microbiology, Zoonosis Science Center, Uppsala University, Uppsala, Sweden.; Marie Bashir Institute for Infectious Diseases and Biosecurity, Charles Perkins Centre, School of Life and Environmental Sciences and Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia.; Public Health Agency of Sweden, Nobels vg 18, SE-171 82 Solna, Sweden.; Kirkeleite I; Division of Infectious Diseases and Environmental Health, Norwegian Institute of Public Health, Lovisenberggata 8, 0456 Oslo, Norway.; Fandinho F; Laboratorio de Bacteriologia da Tuberculose, Centro de Referłncia Professor Helio Fraga-Jacarepagu, Estrada de Curicica 2000, Brazil.; da Silva MA; Laboratorio de Bacteriologia da Tuberculose, Centro de Referłncia Professor Helio Fraga-Jacarepagu, Estrada de Curicica 2000, Brazil.; Perdigao J; Instituto de Investigao do Medicamento, Faculdade de Farmcia, Universidade de Lisboa, Lisboa, Portugal.; Portugal I; Instituto de Investigao do Medicamento, Faculdade de Farmcia, Universidade de Lisboa, Lisboa, Portugal.; Viveiros M; Unidade de Microbiologia Medica, Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisboa, Portugal.; Clark T; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.; Caws M; Liverpool School of Tropical medicine, Department of Clinical Sciences, Liverpool, UK.; Birat-Nepal Medical Trust, Lazimpat, Kathmandu, Nepal.; Dunstan S; Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.; Thai PVK; Pham Ngoc Thach Hospital for TB and Lung Diseases, Ho Chi Minh City, Vietnam.; Lopez B; Instituto Nacional de Enfermedades Infecciosas, ANLIS Carlos Malbran, Buenos Aires, Argentina.; Ritacco V; Instituto Nacional de Enfermedades Infecciosas, ANLIS Carlos Malbran, Buenos Aires, Argentina.; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Buenos Aires, Argentina.; Kitchen A; Department of Anthropology, University of Iowa, Iowa City, IA 52242, USA.; Brown TS; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA.; van Soolingen D; Center for Infectious Disease Research, Diagnostics and Perinatal Screening, National Institute for Public Health and the Environment, P.O. Box 1, 3720 BA Bilthoven, Netherlands.; O'Neill MB; Department of Medical Microbiology and Immunology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53726, USA.; Laboratory of Genetics, University of Wisconsin-Madison, Madison, WI 53706, USA.; Holt KE; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.; Department of Biochemistry and Molecular Biology and Bio21 Institute, University of Melbourne, Melbourne, Victoria, Australia.; Feil EJ; Milner Centre for Evolution, Department of Biology and Biochemistry, University of Bath, Bath BA2 7AY, UK.; Mathema B; Mailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY 10032, USA.; Balloux F; UCL Genetics Institute, University College London, London WC1E 6BT, UK.; Eldholm V; Division of Infectious Diseases and Environmental Health, Norwegian Institute of Public Health, Lovisenberggata 8, 0456 Oslo, Norway. |
| Source: | Science advances [Sci Adv] 2018 Oct 17; Vol. 4 (10), pp. eaat5869. Date of Electronic Publication: 2018 Oct 17 (Print Publication: 2018). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Language: | English |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: eCollection Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Washington, DC : American Association for the Advancement of Science, [2015]- |
| MeSH Terms: | Adaptation, Biological/*genetics ; Mycobacterium tuberculosis/*genetics ; Tuberculosis/*transmission; Drug Resistance, Bacterial/genetics ; Mycobacterium tuberculosis/drug effects ; Tuberculosis/epidemiology ; Tuberculosis/microbiology ; Africa ; Americas ; Biological Evolution ; Europe ; Genetic Variation ; Human Migration ; Humans ; Phylogeography ; Polymorphism, Single Nucleotide |
| Abstract: | On the basis of population genomic and phylogeographic analyses of 1669 Mycobacterium tuberculosis lineage 4 (L4) genomes, we find that dispersal of L4 has been completely dominated by historical migrations out of Europe. We demonstrate an intimate temporal relationship between European colonial expansion into Africa and the Americas and the spread of L4 tuberculosis (TB). Markedly, in the age of antibiotics, mutations conferring antimicrobial resistance overwhelmingly emerged locally (at the level of nations), with minimal cross-border transmission of resistance. The latter finding was found to reflect the relatively recent emergence of these mutations, as a similar degree of local restriction was observed for susceptible variants emerging on comparable time scales. The restricted international transmission of drug-resistant TB suggests that containment efforts at the level of individual countries could be successful. |
| References: | Infect Genet Evol. 2012 Oct;12(7):1362-7. (PMID: 22569099); Mol Biol Evol. 2008 Jul;25(7):1459-71. (PMID: 18408232); Nat Commun. 2015 May 11;6:7119. (PMID: 25960343); Mol Ecol Resour. 2017 Jul;17(4):608-613. (PMID: 27717245); BMC Genomics. 2016 Nov 21;17(1):947. (PMID: 27871225); Nat Commun. 2015 Apr 07;6:6717. (PMID: 25848958); Int J Med Microbiol. 2016 Nov;306(7):580-585. (PMID: 27296510); PLoS One. 2012;7(6):e39754. (PMID: 22761889); Bioinformatics. 2010 Jun 15;26(12):1569-71. (PMID: 20421198); Nat Genet. 2013 Oct;45(10):1176-82. (PMID: 23995134); Bioinformatics. 2009 Jul 15;25(14):1754-60. (PMID: 19451168); PLoS Genet. 2015 Aug 12;11(8):e1005421. (PMID: 26267488); J Clin Microbiol. 2007 Dec;45(12):3891-902. (PMID: 17898156); Nature. 2014 Oct 23;514(7523):494-7. (PMID: 25141181); Elife. 2015 Mar 03;4:. (PMID: 25732036); Nat Commun. 2014 Sep 01;5:4812. (PMID: 25176035); Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):13609-14. (PMID: 26483462); Syst Biol. 2016 Jan;65(1):82-97. (PMID: 26424727); Trends Genet. 2000 Jun;16(6):276-7. (PMID: 10827456); Mem Inst Oswaldo Cruz. 2008 Aug;103(5):489-92. (PMID: 18797764); Mol Biol Evol. 2016 Jun;33(6):1635-8. (PMID: 26921390); Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6526-31. (PMID: 21464295); BMC Infect Dis. 2013 Feb 27;13:110. (PMID: 23446317); Emerg Infect Dis. 2017 Mar;23(3):423-429. (PMID: 28221129); J Clin Microbiol. 2003 Jul;41(7):2878-83. (PMID: 12843016); Nat Genet. 2014 Mar;46(3):279-86. (PMID: 24464101); PLoS Med. 2015 Sep 29;12(9):e1001880. (PMID: 26418737); Mol Biol Evol. 2012 Aug;29(8):1969-73. (PMID: 22367748); N Engl J Med. 2017 Jan 19;376(3):243-253. (PMID: 28099825); BMC Evol Biol. 2007 Nov 08;7:214. (PMID: 17996036); Nucleic Acids Res. 2011 Jul;39(Web Server issue):W475-8. (PMID: 21470960); BMC Genet. 2012 Apr 11;13:27. (PMID: 22494792); Nat Genet. 2016 Dec;48(12):1535-1543. (PMID: 27798628); Microbiol Spectr. 2016 Aug;4(4):. (PMID: 27726782); Bioinformatics. 2011 Aug 1;27(15):2156-8. (PMID: 21653522); Nature. 1998 Jun 11;393(6685):537-44. (PMID: 9634230); Emerg Infect Dis. 2012 Nov;18(11):1802-10. (PMID: 23092584); Fly (Austin). 2012 Apr-Jun;6(2):80-92. (PMID: 22728672); Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):13881-13886. (PMID: 27872285); Mol Biol Evol. 2015 Jan;32(1):268-74. (PMID: 25371430); Genetics. 2002 Jul;161(3):1307-20. (PMID: 12136032); Mol Ecol. 2019 Jul;28(13):3241-3256. (PMID: 31066139); BMC Genomics. 2014 Nov 18;15:991. (PMID: 25407810); Infect Genet Evol. 2012 Jun;12(4):664-70. (PMID: 21835266); Mol Biol Evol. 2013 Jun;30(6):1326-36. (PMID: 23449927); PLoS One. 2012;7(3):e33275. (PMID: 22479378); Nat Genet. 2017 Mar;49(3):395-402. (PMID: 28092681); Virus Evol. 2016 Apr 09;2(1):vew007. (PMID: 27774300); Nat Genet. 2013 Oct;45(10):1183-9. (PMID: 23995135); Sci Rep. 2017 Jul 25;7(1):6484. (PMID: 28744015); J Clin Microbiol. 2016 Mar;54(3):727-33. (PMID: 26763957); Nat Methods. 2017 Jun;14(6):587-589. (PMID: 28481363); Lancet Respir Med. 2017 Mar 15;:. (PMID: 28344011); Genome Med. 2015 May 27;7(1):51. (PMID: 26019726); Trends Microbiol. 2016 Aug;24(8):637-648. (PMID: 27068531); J Clin Microbiol. 2013 Oct;51(10):3277-85. (PMID: 23884993); PLoS Comput Biol. 2009 Sep;5(9):e1000520. (PMID: 19779555); Mol Biol Evol. 2013 May;30(5):1188-95. (PMID: 23418397); PLoS One. 2015 Jul 16;10(7):e0132840. (PMID: 26181760); Lancet Infect Dis. 2014 Mar;14(3):250-5. (PMID: 24268591) |
| Grant Information: | MR/P007597/1 United Kingdom MRC_ Medical Research Council; R01 AI113287 United States AI NIAID NIH HHS; T32 GM007133 United States GM NIGMS NIH HHS |
| Entry Date(s): | Date Created: 20181023 Date Completed: 20190924 Latest Revision: 20250530 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC6192687 |
| DOI: | 10.1126/sciadv.aat5869 |
| PMID: | 30345355 |
| Database: | MEDLINE |
Journal Article; Research Support, Non-U.S. Gov't